Sargent Bickham Lagudis LLC Amgen Inc Transaction History

Sargent Bickham Lagudis LLC

$1.22 Billion
Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Amgen Inc stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 1,714 shares of AMGN stock, worth $504,824. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,714

Previous 1,728 0.81%

Holding current value

$504,824

Previous $390,000 15.38%

% of portfolio

0.04%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $3,206 - $4,074	-14 Reduced 0.81%	1,714 $0
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $3,460 - $3,851	15 Added 0.88%	1,728 $420,000
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $3,069 - $3,395	-14 Reduced 0.81%	1,713 $415,000
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $4,574 - $5,234	-23 Reduced 1.31%	1,727 $389,000
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $11,250 - $13,181	-53 Reduced 2.94%	1,750 $372,000
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $32,467 - $36,020	-139 Reduced 7.16%	1,803 $440,000
Q1 2021 May 24, 2021	BUY	$221.91 - $258.6 $16,643 - $19,395	75 Added 4.02%	1,942 $483,000
Q4 2020 May 24, 2021	SELL	$216.38 - $257.67 $16,228 - $19,325	-75 Reduced 3.86%	1,867 $429,000
Q4 2020 May 24, 2021	BUY	$216.38 - $257.67 $88,932 - $105,902	411 Added 26.85%	1,942 $483,000
Q1 2020 Sep 07, 2021	SELL	$182.24 - $241.7 $12,027 - $15,952	-66 Reduced 4.13%	1,531 $310,000
Q4 2019 Sep 14, 2021	BUY	$189.21 - $243.2 $6,243 - $8,025	33 Added 2.11%	1,597 $385,000
Q3 2019 Sep 14, 2021	BUY	$174.11 - $208.62 $7,660 - $9,179	44 Added 2.89%	1,564 $303,000
Q2 2019 Sep 13, 2021	SELL	$166.7 - $195.41 $3,834 - $4,494	-23 Reduced 1.49%	1,520 $280,000
Q2 2018 Sep 13, 2021	SELL	$166.05 - $186.51 $1,660 - $1,865	-10 Reduced 0.64%	1,543 $285,000
Q3 2017 Sep 13, 2021	SELL	$167.29 - $191.0 $16,729 - $19,100	-100 Reduced 6.05%	1,553 $290,000
Q2 2017 Sep 13, 2021	SELL	N/A	-2 Reduced 0.12%	1,653 $285,000
Q4 2016 Sep 13, 2021	SELL	N/A	-37 Reduced 2.19%	1,655 $242,000
Q3 2016 Sep 13, 2021	BUY	N/A	9 Added 0.53%	1,692 $282,000
Q2 2016 Sep 07, 2021	BUY	N/A	25 Added 1.51%	1,683 $256,000
Q1 2016 Sep 07, 2021	BUY	N/A	1,658	1,658 $249,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Account

Sargent Bickham Lagudis LLC Amgen Inc Transaction History